Shares

15 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2023

Aug 11, 2023

SELL
$0.35 - $3.28 $6,923 - $64,878
-19,780 Reduced 0.78%
2,525,000 $883,000
Q1 2023

May 12, 2023

BUY
$3.28 - $4.81 $592,696 - $869,166
180,700 Added 7.64%
2,544,780 $8.8 Million
Q4 2022

Feb 13, 2023

SELL
$3.65 - $4.82 $602,250 - $795,300
-165,000 Reduced 6.52%
2,364,080 $10.6 Million
Q3 2022

Nov 10, 2022

SELL
$2.66 - $3.97 $53,200 - $79,400
-20,000 Reduced 0.78%
2,529,080 $9.21 Million
Q2 2022

Aug 12, 2022

BUY
$2.42 - $4.05 $83,683 - $140,049
34,580 Added 1.38%
2,549,080 $6.76 Million
Q1 2022

May 16, 2022

BUY
$3.45 - $5.83 $345,000 - $583,000
100,000 Added 4.14%
2,514,500 $9.86 Million
Q4 2021

Feb 14, 2022

BUY
$4.89 - $7.59 $2.43 Million - $3.77 Million
496,300 Added 25.87%
2,414,500 $13.3 Million
Q3 2021

Nov 15, 2021

BUY
$5.18 - $7.41 $259,000 - $370,500
50,000 Added 2.68%
1,918,200 $13.8 Million
Q2 2021

Aug 16, 2021

BUY
$3.94 - $6.75 $721,020 - $1.24 Million
183,000 Added 10.86%
1,868,200 $12.3 Million
Q1 2021

May 17, 2021

BUY
$4.03 - $7.25 $2.76 Million - $4.97 Million
685,200 Added 68.52%
1,685,200 $7.33 Million
Q4 2020

Feb 16, 2021

BUY
$2.78 - $4.5 $611,600 - $990,000
220,000 Added 28.21%
1,000,000 $3.82 Million
Q3 2020

Nov 16, 2020

SELL
$2.12 - $3.53 $360,400 - $600,100
-170,000 Reduced 17.89%
780,000 $2.73 Million
Q2 2020

Aug 14, 2020

SELL
$1.66 - $2.73 $249,000 - $409,500
-150,000 Reduced 13.64%
950,000 $2.13 Million
Q1 2020

May 15, 2020

BUY
$1.35 - $4.05 $1.19 Million - $3.58 Million
885,000 Added 411.63%
1,100,000 $2.75 Million
Q4 2019

Feb 14, 2020

BUY
$2.3 - $4.6 $494,499 - $988,999
215,000 New
215,000 $907,000

Others Institutions Holding VRAY

About ViewRay, Inc.


  • Ticker VRAY
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 181,010,000
  • Market Cap $1.81M
  • Description
  • ViewRay, Inc. designs, manufactures, and markets magnetic resonance imaging (MRI) guided radiation therapy systems to image and treat cancer patients in the United States, France, Taiwan, the United Kingdom, and internationally. The company provides MRIdian, which is an MRI guided radiation therapy system that addresses beam distortion, skin tox...
More about VRAY
Track This Portfolio

Track Needham Investment Management LLC Portfolio

Follow Needham Investment Management LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Needham Investment Management LLC, based on Form 13F filings with the SEC.

News

Stay updated on Needham Investment Management LLC with notifications on news.